# ATEA PHARMACEUTICALS INC (AVIR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AVIR/

- Reporting holders: 3
- Reported value: $28.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $22.9K | 4,397 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.6K | 494 | 0.0% | 16 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.6K | 490 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $28.0K |
| Q2 2026 | 126 | $288.6M |
| Q1 2026 | 127 | $323.5M |
| Q4 2025 | 111 | $204.4M |
| Q3 2025 | 113 | $159.9M |
| Q2 2025 | 106 | $189.8M |
| Q1 2025 | 105 | $158.5M |
| Q4 2024 | 107 | $189.1M |
| Q3 2024 | 106 | $196.8M |
| Q2 2024 | 103 | $193.6M |
| Q1 2024 | 113 | $230.3M |
| Q4 2023 | 109 | $170.3M |